GL1001
Phase 2- Indications
- Inflammatory bowel disease, Gastrointestinal disorders
Company intelligence / Profile preview
Gene Logic was a pioneering genomics and bioinformatics company founded in the mid-'90s that evolved into a leader in drug repositioning. It developed proprietary gene expression databases, proteomics technologies, and sophisticated bioinformatics tools to support pharmaceutical R&D. The company's main business model shifted toward partnering with major pharma companies to find new uses for discontinued or deprioritized clinical-stage compounds using its Drug Repositioning Program. At its peak, it had hundreds of employees worldwide and partnerships with top-tier pharma companies such as Pfizer, Roche, Millennium Pharmaceuticals, Merck Serono, Organon, among others. The company was publicly traded under the symbol GLGC but has since been acquired/merged out of existence as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gene Logic.